Indicator Metadata

NamePercentage of Public Drug Program Spending on Generic Drugs
Short/Other Names

Not applicable

DescriptionThe rate of public drug program spending on generic drugs
InterpretationThis indicator is interpreted as the proportion of public drug program spending for generic drug products.
HSP Framework Dimension

Health System Inputs and Characteristics: Efficient allocation of resources

Areas of Need

Not applicable

Geographic Coverage

Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia

Reporting Level/Disaggregation

Province/Territory

Indicator Results

https://secure.cihi.ca/estore/productSeries.htm?pc=PCC1011

Identifying Information
NamePercentage of Public Drug Program Spending on Generic Drugs
Short/Other Names

Not applicable

Indicator Description and Calculation
DescriptionThe rate of public drug program spending on generic drugs
Calculation: Description

Total public drug program spending on generic drugs divided by total public drug program spending

Unit of Analysis: Spending from public drug programs

Calculation: Geographic Assignment

Place of residence

Calculation: Type of Measurement

Percentage or proportion

Calculation: Adjustment Applied

None

Calculation: Method of Adjustment

Not applicable

Denominator

Description:
Total public drug program spending
Inclusions:
All claims accepted by public drug programs
Exclusions:
Any claims not submitted to or accepted by public drug programs, including claims submitted to a private insurer or cases where the individual pays out of pocket

Numerator

Description:
Total public drug program spending on generic drug products
Inclusions:
All claims for generic drugs accepted by public drug programs
Exclusions:
1. Any claims not submitted to or accepted by public drug programs, including claims submitted to a private insurer or cases where the individual pays out of pocket

2. Claims for brand name products

Background, Interpretation and Benchmarks
Rationale

This indicator measures the proportion of public drug program spending that generic drugs account for.

Interpretation

This indicator is interpreted as the proportion of public drug program spending for generic drug products.

HSP Framework Dimension

Health System Inputs and Characteristics: Efficient allocation of resources

Areas of Need

Not applicable

Targets/Benchmarks

Not applicable

References

Not applicable

Availability of Data Sources and Results
Data Sources

NPDUIS Database

Available Data Years

Type of Year:
Calendar
First Available Year:
2000
Last Available Year:
2015

Geographic Coverage

Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia

Reporting Level/Disaggregation

Province/Territory

Result Updates
Update Frequency

Whenever required for analytical product or data request

Indicator Results

Web Tool:
Prescribed Drug Spending in Canada
URL: https://secure.cihi.ca/estore/productSeries.htm?pc=PCC1011

Updates

Not applicable

Quality Statement
Caveats and Limitations

– Includes only drugs claimed through public drug programs

– Excludes any drugs claimed through a private drug plan or purchased over the counter

Trending Issues

All data is not available for all years:

– Manitoba, Saskatchewan, Alberta, New Brunswick: From January 2000

– Nova Scotia: From April 2001

– Prince Edward Island: From April 2004

– British Columbia: From January 2006

– Yukon: From January 2007

– Newfoundland and Labrador: From April 2008

– Ontario: From April 2010

– First Nations and Inuit Health Branch: From October 2010

Comments

Not applicable